id: nod1_ligand_exposure_with_low_cerulein_to_pathologic_innate_immune_response
name: NOD1 Ligand Exposure with Low-Dose Cerulein â†’ Pathologic Innate Immune Response
from_node:
  node_id: nod1_ligand_exposure_with_low_cerulein
  node_name: NOD1 Ligand Exposure with Low-Dose Cerulein
to_node:
  node_id: pathologic_innate_immune_response
  node_name: Pathologic Innate Immune Response
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Low doses of cerulein administered with NOD1 ligand create permissive conditions'
- 'Step 2: NOD1 ligand activates nucleotide-binding oligomerization domain 1 receptors'
- 'Step 3: NOD1-mediated signaling induces pathologic innate immune response'
- 'Step 4: Pathologic immune response causes pancreatic damage and inflammation'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Kosuke Minaga et al. 2022. "A Mouse Model of Acute and Chronic
    Pancreatitis." *Current Protocols*. https://doi.org/10.1002/cpz1.422
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:07.167048'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: cerulein_dose_level
  direction: strengthens
  strength: strong
  description: Low-dose cerulein alone causes minimal damage, but when combined with
    NOD1 ligand induces significant pathologic response, demonstrating synergistic
    effect
